The spectrum of mutations identified in Cypriot patients with phenylalanine hydroxylase deficiency detected through neonatal screening

详细信息	查看全文 | 推荐本文 |

• 作者：Theodoros Georgiou^a ; Gladys Ho^b ; Marios Vogazianos^c ; Maria Dionysiou^a ; Alexia Nicolaou^c ; Georgia Chappa^d ; Paola Nicolaides^e ; Goula Stylianidou^d ; ¹ ; John Christodoulou^b ; ^f ; Anthi Drousiotou^a ; ^{anthidr@cing.ac.cy}
• 关键词：Phenylketonuria ; Phenylalanine hydroxylase ; PAH ; Neonatal screening ; Mutation analysis ; Cyprus
• 刊名：Clinical Biochemistry
• 出版年：2012
• 期刊代码：55_00099120
• 类别：med
• 出版时间：May, 2012
• 卷：45
• 期：7-8
• 页码：588-592
• 文件大小：332 K

摘要

Objectives

The purpose of this study was to identify the mutations responsible for phenylalanine hydroxylase deficiency in Cypriot patients detected through neonatal screening.

Design and Methods

Analysis of the PAH gene was performed by direct sequencing of the patients' genomic DNA, MLPA analysis and real-time PCR.

Results

Among 22 independent alleles thirteen previously described mutations were detected (detection rate 100%), all in compound heterozygosity: p.Arg395Gly (18.2%), c.168 + 5 G > C (13.6%), p.EX3del (9%), c.1066-11 G > A (9%), p.Ala403Val (9%), p.Glu178Gly (9%), p.Ser70Pro (4.5%), p.Arg241His (4.5%), p.Phe55fs (4.5%), p.Arg158Gln (4.5%), p.Asp222Gly (4.5%), p.Ala300Ser (4.5%), p.Pro225Thr (4.5%). Of the ten different genotypes, three have been previously reported to be associated with a mild clinical phenotype and to respond to tetrahydrobiopterin (BH₄) administration.

Conclusions

Marked genetic heterogeneity was found in Cypriot patients with hyperphenylalaninemia with two mutations accounting for 32%of the alleles. Most of the mutations detected have been found in other European and Mediterranean populations.